Sympathetic Renal Denervation for the Treatment of Hypertension: A Review of Current Progress, Limitations, Techniques, and the Future
Tushar Sharma*, Anjay Rastogi, Rishi Talwar, Reza Khosravani Goshtaseb, Rohit Kumar , Mohamad Rashid
Identifiers and Pagination:Year: 2013
First Page: 58
Last Page: 62
Publisher Id: TOUNJ-6-58
Article History:Received Date: 5/8/2013
Revision Received Date: 5/9/2013
Acceptance Date: 12/9/2013
Electronic publication date: 31/10/2013
Collection year: 2014
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Although the etiology of hypertension is complicated and multifactorial, the role of sympathetic overactivity as part of the pathogenesis in essential hypertension has been well described in the literature. A promising new treatment modality of Renal Sympathetic Denervation has become prominent with very enthusiastic support. This paper suggests that while the support may be overhyped, this new treatment modality may, with further research, become a powerful tool for a specific patient population. The history, benefits, and limitations of the procedure are discussed including, but not limited to, proper screening methodology, technical aspects, and procedural complications.